Brief: Artiva Biotherapeutics Inc Thad Huston To Separate As CFO Effective May 22, 2026
19/05/2026 13:51
May 19 (Reuters) - Artiva Biotherapeutics Inc ARTV.O: ARTIVA BIOTHERAPEUTICS INC - THAD HUSTON TO SEPARATE AS CFO EFFECTIVE MAY 22, 2026 - SEC FILING Source text: [ID:n0001193125-26-229714] Further company coverage: ARTV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Artiva Biotherapeutics
See all newsBrief: Artiva Biotherapeutics Provides Update On Planned Allonk® Data Disclosures And Development Milestones For The Remainder Of 2026
Artiva Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Artiva Biotherapeutics Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Artiva Biotherapeutics Inc Thad Huston To Separate As CFO Effective May 22, 2026
U.S. STOCKS ON THE MOVE-Corning, BILL Holdings, Moderna